Literature DB >> 29577935

Parathyroid Hormone-Like Hormone Induces Epithelial-to-Mesenchymal Transition of Intestinal Epithelial Cells by Activating the Runt-Related Transcription Factor 2.

Shuying He1, Minmin Xue2, Cuiping Liu3, Fang Xie1, Lan Bai4.   

Abstract

Epithelial-to-mesenchymal transition (EMT) is a key contributor to fibroblast activation in fibrosis of multiple organs, including the intestine. Parathyroid hormone-like hormone (PTHLH) is an important factor in renal fibrosis and regulates several processes, including EMT. Herein, we investigated the role of PTHLH-induced EMT in intestinal fibrosis associated with Crohn disease. The expression levels of the EMT-related proteins, PTHLH, and parathyroid hormone receptor 1 (PTH1R) in intestinal tissues were determined by immunohistochemistry, and our results revealed that PTHLH and PTH1R were significantly elevated and associated with EMT marker expression. Moreover, neutralizing PTH1R and antagonizing PTHLH bioactivity prevented transforming growth factor-β1-induced EMT. PTH1R can propagate the protein kinase A (PKA) signal and activate downstream nuclear transcription factors, including runt-related transcription factor 2 (Runx2). In addition, lentiviral vector-PTHLH-treated mice were highly sensitive to 2,4,6-trinitrobenzene sulfonic acid, and analysis of the PTHLH-PTH1R axis revealed the involvement of PKA-Runx2 in PTHLH-induced EMT. Our results indicate that PTHLH triggered EMT in intestinal epithelial cells through the PKA-Runx2 pathway, which might serve as a therapeutic target for intestinal fibrosis in Crohn disease.
Copyright © 2018 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29577935     DOI: 10.1016/j.ajpath.2018.03.003

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  5 in total

1.  Parathyroid Hormone-Related Protein Inhibition Blocks Triple-Negative Breast Cancer Expansion in Bone Through Epithelial to Mesenchymal Transition Reversal.

Authors:  Jiarong Li; Anne Camirand; Mahvash Zakikhani; Karine Sellin; Yubo Guo; XiaoRui Luan; Catalin Mihalcioiu; Richard Kremer
Journal:  JBMR Plus       Date:  2022-04-14

2.  PTHrP Drives Pancreatic Cancer Growth and Metastasis and Reveals a New Therapeutic Vulnerability.

Authors:  Jason R Pitarresi; Robert J Norgard; Anna M Chiarella; Kensuke Suzuki; Basil Bakir; Varun Sahu; Jinyang Li; Jun Zhao; Benoît Marchand; Maximilian D Wengyn; Antony Hsieh; Il-Kyu Kim; Amy Zhang; Karine Sellin; Vivian Lee; Shigetsugu Takano; Yoji Miyahara; Masayuki Ohtsuka; Anirban Maitra; Faiyaz Notta; Richard Kremer; Ben Z Stanger; Anil K Rustgi
Journal:  Cancer Discov       Date:  2021-02-15       Impact factor: 38.272

3.  Interleukin-17 Weakens the NAFLD/NASH Process by Facilitating Intestinal Barrier Restoration Depending on the Gut Microbiota.

Authors:  Shuying He; Shudan Cui; Wen Song; Yonghong Jiang; Hongsheng Chen; Dongjiang Liao; Xinpeng Lu; Jun Li; Xueqing Chen; Liang Peng
Journal:  mBio       Date:  2022-03-10       Impact factor: 7.786

Review 4.  Mechanism of fibrosis and stricture formation in Crohn's disease.

Authors:  Johannes Alfredsson; Mary Jo Wick
Journal:  Scand J Immunol       Date:  2020-12       Impact factor: 3.487

5.  Effect and Mechanism of TL1A Expression on Epithelial-Mesenchymal Transition during Chronic Colitis-Related Intestinal Fibrosis.

Authors:  Jia Wenxiu; Yang Mingyue; Han Fei; Luo Yuxin; Wu Mengyao; Li Chenyang; Song Jia; Zhang Hong; David Q Shih; Stephan R Targan; Zhang Xiaolan
Journal:  Mediators Inflamm       Date:  2021-06-25       Impact factor: 4.711

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.